Press & News

Press & News2019-02-21T23:56:09+00:00

Latest Articles

Browse a selection of of ImaginAb press and news below.

ImaginAb Inc. Announces Strategic Collaboration with Boehringer Ingelheim to Develop New Technology for Monitoring Anti-tumor Activity of the Immune System

ImaginAb announced today a collaboration with Boehringer Ingelheim, one of the world’s 20 leading pharmaceutical companies, to further develop ImaginAb’s CD8 T Cell imaging technology.

Load More Posts